Serine racemase modulation for improving brain insulin resistance: An Editorial Highlight for "Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid-β oligomers": An Editorial Highlight for "Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid-β oligomers"

J Neurochem. 2022 Oct;163(1):6-7. doi: 10.1111/jnc.15688. Epub 2022 Aug 22.

Abstract

This Editorial highlights an interesting study in the current issue of the Journal of Neurochemistry in which Zhou et al. report new data showing that the ablation of serine racemase increases local insulin production in neurons of the hippocampus. The authors explored some of the possible mechanisms mediating the interaction between dampening production of D-serine and the local synthesis of insulin, and they further propose that stimulating insulin production could counteract hippocampal insulin resistance in Alzheimer's disease (AD). Most importantly, they leave open a number of questions that need to be experimentally addressed to ascertain whether D-serine modulation of neuronal insulin expression can effectively improve insulin sensitivity in AD, as well as in metabolic disease with neurological impact.

Keywords: Alzeimer's disease; D-serine; insulin; metabolism.

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Brain / metabolism
  • Hippocampus / metabolism
  • Humans
  • Insulin / pharmacology
  • Insulin Resistance*
  • Racemases and Epimerases
  • Serine / metabolism

Substances

  • Amyloid beta-Peptides
  • Insulin
  • Serine
  • Racemases and Epimerases
  • serine racemase